Compile Data Set for Download or QSAR
maximum 50k data
Found 231 of ic50 for UniProtKB: Q96D31
LigandPNGBDBM652093(US11905244, Compound 112)
Affinity DataIC50:  0.200nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652068(US11905244, Compound 87)
Affinity DataIC50:  0.950nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652092(US11905244, Compound 111)
Affinity DataIC50:  1.60nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652087(US11905244, Compound 106)
Affinity DataIC50:  5.01nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652094(US11905244, Compound 113)
Affinity DataIC50:  5.83nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652096(US11905244, Compound 115)
Affinity DataIC50:  5.84nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652067(US11905244, Compound 86)
Affinity DataIC50:  6.34nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652083(US11905244, Compound 102)
Affinity DataIC50:  9.20nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652047(US11905244, Compound 66)
Affinity DataIC50:  10.5nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652077(US11905244, Compound 96)
Affinity DataIC50:  10.9nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652082(US11905244, Compound 101)
Affinity DataIC50:  11.2nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652043(US11905244, Compound 62)
Affinity DataIC50:  11.3nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652060(US11905244, Compound 79)
Affinity DataIC50:  11.7nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652034(US11905244, Compound 53)
Affinity DataIC50:  13nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652081(US11905244, Compound 100)
Affinity DataIC50:  14.8nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652084(US11905244, Compound 103)
Affinity DataIC50:  15.8nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652080(US11905244, Compound 99)
Affinity DataIC50:  18.2nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM141416(US10668051, Compound Example 67 | US8921364, 67)
Affinity DataIC50:  20.4nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141426(US10668051, Compound Example 84 | US8921364, 84)
Affinity DataIC50:  20.8nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM652079(US11905244, Compound 98)
Affinity DataIC50:  21.2nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM652063(US11905244, Compound 82)
Affinity DataIC50:  22.4nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM141438(US10668051, Compound Example 104 | US8921364, 104)
Affinity DataIC50:  23nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM652045(US11905244, Compound 64)
Affinity DataIC50:  24.9nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM50204536(CHEMBL3984105)
Affinity DataIC50:  26nMAssay Description:Inhibition of Orai1 (unknown origin) by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM652046(US11905244, Compound 65)
Affinity DataIC50:  30.6nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM141428(US10668051, Compound Example 87 | US8921364, 87)
Affinity DataIC50:  32.6nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141421(US10668051, Compound Example 78 | US8921364, 78)
Affinity DataIC50:  34.1nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM141424(US10668051, Compound Example 82 | US8921364, 82)
Affinity DataIC50:  35.7nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141396(US10668051, Compound Example 7 | US8921364, 7)
Affinity DataIC50:  36.4nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141444(US10668051, Compound Example 114 | US8921364, 114)
Affinity DataIC50:  37.6nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM152937(US8993612, 20)
Affinity DataIC50:  39.2nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141442(US10668051, Compound Example 111 | US8921364, 111)
Affinity DataIC50:  47.2nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141419(US10668051, Compound Example 74 | US8921364, 74)
Affinity DataIC50:  48nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141425(US10668051, Compound Example 83 | US8921364, 83)
Affinity DataIC50:  48.2nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141418(US10668051, Compound Example 72 | US8921364, 72)
Affinity DataIC50:  48.2nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141441(US10668051, Compound Example 108 | US8921364, 108)
Affinity DataIC50:  50.6nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM152932(US8993612, 6)
Affinity DataIC50:  51.3nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141448(US10668051, Compound Example 126 | US8921364, 126)
Affinity DataIC50:  52.6nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM152936(US8993612, 18)
Affinity DataIC50:  53.4nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141439(US10668051, Compound Example 106 | US8921364, 106)
Affinity DataIC50:  60nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141402(US10668051, Compound Example 28 | US8921364, 28)
Affinity DataIC50:  60.3nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM652002(US11905244, Compound 21)
Affinity DataIC50:  60.3nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
LigandPNGBDBM141393(US10668051, Compound Example 1 | US8921364, 1)
Affinity DataIC50:  62.4nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141443(US10668051, Compound Example 113 | US8921364, 113)
Affinity DataIC50:  62.6nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141412(US10668051, Compound Example 56 | US8921364, 56)
Affinity DataIC50:  63.2nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141409(US10668051, Compound Example 49 | US8921364, 49)
Affinity DataIC50:  65.5nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141440(US10668051, Compound Example 107 | US8921364, 107)
Affinity DataIC50:  70.3nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141411(US10668051, Compound Example 53 | US8921364, 53)
Affinity DataIC50:  72nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM141445(US10668051, Compound Example 122 | US8921364, 122)
Affinity DataIC50:  72.1nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM652044(US11905244, Compound 63)
Affinity DataIC50:  74.4nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
Displayed 1 to 50 (of 231 total ) | Next | Last >>
Jump to: